InsidersTradesSigma
鹭燕医药 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 鹭燕医药 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 鹭燕医药 has published 9 insider filings. Market capitalisation: €8.2bn. The latest transaction was disclosed on 28 November 2024 (Sale). Among the most active insiders: 雷鸣. Every trade is openly available.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
9 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,227 of 25,898 companies
46.7
score / 100
Value67
Quality26
FCF yld11%
Earn yld6.8%
EV/EBITDA13.0x
ROE8.3%
Gross mgn7.1%
Net mgn1.3%
Debt/EBITDA7.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 November 2024
Declarations9 total
9 of 9 declarations